Journal of Clinical Endocrinology & Metabolism, Vol 80, 3284-3286, Copyright © 1995 by Endocrine Society

ARTICLES

The free form of insulin-like growth factor I increases in circulation during normal human pregnancy

T Hasegawa, Y Hasegawa, M Takada and Y Tsuchiya
Division of Endocrinology and Metabolism, Tokyo Metropolitan Kiyose Children's Hospital, Japan.

The main circulating insulin-like growth factor-binding protein (IGFBP) in human, IGFBP-3, markedly decreases during pregnancy, as determined by Western ligand blotting, and its decrease is due to an endogenous pregnancy-related serum IGFBP-3 proteolytic activity. Proteolysis of IGFBP-3 may result in the free form of IGF-I (fIGF-I) being liberated from or weakly bound to IGFBP-3 fragments. The purpose of this study was to determine the plasma concentration of fIGF-I and the mechanism of fIGF-I regulation during normal human pregnancy. We studied 19 normal pregnant women at 6-8 weeks gestation, 24 normal pregnant women at 28-30 weeks gestation, and 25 nonpregnant women. We measured plasma fIGF-I using a recently established immunoradiometric assay. We also measured plasma total IGF-I (free plus complexed forms of IGF-I) using immunoradiometric assay, and IGFBP-3 proteolytic activity using a IGFBP- 3 protease assay. fIGF-I levels at 6-8 weeks gestation (4.11 +/- 0.23 ng/mL) and at 28-30 weeks gestation (3.67 +/- 0.21 ng/mL) were significantly higher than that in nonpregnant women (2.48 +/- 0.12 ng/mL; P < 0.001 in both). Total IGF-I levels at 6-8 weeks gestation (168.0 +/- 9.1 ng/mL) and at 28-30 weeks gestation (241.5 +/- 19.0 ng/mL) were significantly lower than that in nonpregnant women (283.9 +/- 12.3 ng/mL; P < 0.001 at 6-8 weeks gestation and P < 0.05 at 28-30 weeks gestation). All pregnant serum studied had IGFBP-3 proteolytic activity. These data indicate that during normal human pregnancy, circulatory fIGF-I increases, probably due to IGFBP-3 proteolytic activity.

This article has been cited by other articles:

				L. D. Payet, S. M. Firth, and R. C. Baxter The Role of the Acid-Labile Subunit in Regulating Insulin-Like Growth Factor Transport across Human Umbilical Vein Endothelial Cell Monolayers J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2382 - 2389. [Abstract] [Full Text] [PDF]

				L. Rosendal, H. Langberg, A. Flyvbjerg, J. Frystyk, H. Orskov, and M. Kjar Physical capacity influences the response of insulin-like growth factor and its binding proteins to training J Appl Physiol, November 1, 2002; 93(5): 1669 - 1675. [Abstract] [Full Text] [PDF]

				D. Nemet, Y. Oh, H.-S. Kim, M. Hill, and D. M. Cooper Effect of Intense Exercise on Inflammatory Cytokines and Growth Mediators in Adolescent Boys Pediatrics, October 1, 2002; 110(4): 681 - 689. [Abstract] [Full Text] [PDF]

				R. C. Baxter What Is the Significance of IGF-Binding Protein-3 Proteolysis in the Circulation? J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 5087 - 5088. [Full Text] [PDF]

				M. Binoux Tools Now Exist to Measure Circulating IGF-Binding Protein-3 Proteolysis, to Study Its Regulation and Its Effects on IGF-I Bioavailability J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 5088 - 5089. [Full Text] [PDF]

				N. Miyakoshi, X. Qin, Y. Kasukawa, C. Richman, A. K. Srivastava, D. J. Baylink, and S. Mohan Systemic Administration of Insulin-Like Growth Factor (IGF)-Binding Protein-4 (IGFBP-4) Increases Bone Formation Parameters in Mice by Increasing IGF Bioavailability via an IGFBP-4 Protease-Dependent Mechanism Endocrinology, June 1, 2001; 142(6): 2641 - 2648. [Abstract] [Full Text] [PDF]

				C. LASSARRE and M. BINOUX Measurement of Intact Insulin-Like Growth Factor-Binding Protein-3 in Human Plasma Using a Ligand Immunofunctional Assay J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1260 - 1266. [Abstract] [Full Text]

				D. Byun, S. Mohan, M. Yoo, C. Sexton, D. J. Baylink, and X. Qin Pregnancy-Associated Plasma Protein-A Accounts for the Insulin-Like Growth Factor (IGF)-Binding Protein-4 (IGFBP-4) Proteolytic Activity in Human Pregnancy Serum and Enhances the Mitogenic Activity of IGF by Degrading IGFBP-4 in Vitro J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 847 - 854. [Abstract] [Full Text]

				B. Argüelles, V. Barrios, J. Pozo, M. T. Muñoz, and J. Argente Modifications of Growth Velocity and the Insulin-Like Growth Factor System in Children with Acute Lymphoblastic Leukemia: A Longitudinal Study J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4087 - 4092. [Abstract] [Full Text]

				A. Eliakim, Y. Oh, and D. M. Cooper Effect of single wrist exercise on fibroblast growth factor-2, insulin-like growth factor, and growth hormone Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2000; 279(2): R548 - R553. [Abstract] [Full Text] [PDF]

				A. Halhali, A. R. Tovar, N. Torres, H. Bourges, M. Garabedian, and F. Larrea Preeclampsia Is Associated with Low Circulating Levels of Insulin-Like Growth Factor I and 1,25-Dihydroxyvitamin D in Maternal and Umbilical Cord Compartments J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 1828 - 1833. [Abstract] [Full Text]

				Y. Hasegawa, K. Fujii, M. Yamada, Y. Igarashi, K. Tachibana, T. Tanaka, K. Onigata, Y. Nishi, S. Kato, and T. Hasegawa Identification of Novel Human GH-1 Gene Polymorphisms that Are Associated with Growth Hormone Secretion and Height J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1290 - 1295. [Abstract] [Full Text]

				I. M. Chapman, M. L. Hartman, K. S. Pieper, E. H. Skiles, S. S. Pezzoli, R. L. Hintz, and M. O. Thorner Recovery of Growth Hormone Release from Suppression by Exogenous Insulin-Like Growth Factor I (IGF-I): Evidence for a Suppressive Action of Free Rather Than Bound IGF-I J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2836 - 2842. [Abstract] [Full Text]

				S. Rajaram, D. J. Baylink, and S. Mohan Insulin-Like Growth Factor-Binding Proteins in Serum and Other Biological Fluids: Regulation and Functions Endocr. Rev., December 1, 1997; 18(6): 801 - 831. [Abstract] [Full Text]

				D. L. Mortensen, W. B. Won, J. Siu, D. Reifsnyder, M. Gironella, T. Etcheverry, and R. G. Clark Insulin-Like Growth Factor Binding Protein-1 Induces Insulin Release in the Rat Endocrinology, May 1, 1997; 138(5): 2073 - 2080. [Abstract] [Full Text] [PDF]

				Y. Hasegawa, T. Hasegawa, K. Fujii, H. Konii, M. Anzo, T. Aso, S. Koto, M. Takada, and Y. Tsuchiya High Ratios of Free to Total Insulin-Like Growth Factor-I in Early Infancy J. Clin. Endocrinol. Metab., January 1, 1997; 82(1): 156 - 158. [Abstract] [Full Text] [PDF]